Exploring the association between COVID-19 and male genital cancer risk in European population: evidence from mendelian randomization analysis
- PMID: 37749495
- PMCID: PMC10521436
- DOI: 10.1186/s12863-023-01158-x
Exploring the association between COVID-19 and male genital cancer risk in European population: evidence from mendelian randomization analysis
Abstract
Background: Recently accumulated evidence indicates a potential association between COVID-19 and elevated susceptibility to cancer, including male genital cancer. However, the causal nature of this relationship remains unclear.
Methods: In this Mendelian randomization (MR) study, we investigated the potential causal relationship between COVID-19 and male genital cancer using genetic variants as instrumental variables. We utilized summary statistics from two large-scale genome-wide association studies of COVID-19 hospitalized Vs. controls, as well as data from a population-based male genital cancer database based on European ancestry. We applied stringent quality control measures to select instrumental variables, including checking for linkage disequilibrium, removing low-quality variants, and assessing the strength of the instruments using the F-statistic. We conducted the MR analysis using the inverse-variance weighted method and several sensitivity analyses (including MR Egger and Weighted Median MR analysis) to test the robustness of our results.
Results: Our MR analysis revealed no causal associations between COVID-19 hospitalization and the incidence of male genital cancer. In the inverse-variance weighted analysis, no causal associations were observed between patients with COVID-19 hospitalization and the incidence of male genital cancer (odds ratio = 1.000 and 95% confidence interval = 0.998-1.001, p = 0.668). The estimated causal effect was consistent across all sensitivity analyses (including the Weighted Median, the MR Egger analysis, and the MR PROSSO analysis). The leave-one-out analysis showed that there was no any sing Single-nucleotide polymorphism significantly influencing our results.
Conclusions: Our study provides evidence that there is no causal association between COVID-19 hospitalization and male genital cancer.
Keywords: COVID-19; Causal associations; Genetic variants; Male genital cancer; Mendelian randomization.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.BMC Med Genomics. 2021 Nov 13;14(1):269. doi: 10.1186/s12920-021-01127-2. BMC Med Genomics. 2021. PMID: 34774031 Free PMC article.
-
Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study.BMC Cardiovasc Disord. 2022 Jun 11;22(1):262. doi: 10.1186/s12872-022-02702-w. BMC Cardiovasc Disord. 2022. PMID: 35690714 Free PMC article.
-
Association between COVID-19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study.Brain Behav. 2023 Nov;13(11):e3239. doi: 10.1002/brb3.3239. Epub 2023 Aug 28. Brain Behav. 2023. PMID: 37638499 Free PMC article.
-
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study.Pregnancy Hypertens. 2021 Dec;26:17-23. doi: 10.1016/j.preghy.2021.08.112. Epub 2021 Aug 19. Pregnancy Hypertens. 2021. PMID: 34428710 Review.
-
Mendelian randomization for nephrologists.Kidney Int. 2023 Dec;104(6):1113-1123. doi: 10.1016/j.kint.2023.09.016. Epub 2023 Sep 30. Kidney Int. 2023. PMID: 37783446 Review.
Cited by
-
Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis.Cancer Med. 2024 Mar;13(5):e7067. doi: 10.1002/cam4.7067. Cancer Med. 2024. PMID: 38468558 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical